THRIVE
Dead / Abandoned — Abandoned — no statement of use filed (as of 30 Jan 2023)
What this means for you
This application is over — abandoned 30 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88249081
- Mark type
- Stylized text
- Filed
- 03 Jan 2019
- Published for opposition
- 29 Oct 2019
- Abandoned
- 30 Jan 2023
- Attorney of record
- Brian R. Landry
Goods and services
- Class 005 — Pharmaceuticals: Preparations for use in the treatment of autosomal dominant disorders; preparations for use in the treatment of Amyotrophic Lateral Sclerosis (ALS); preparations for use in the treatment of Alpha-1 Antitrypsin Deficiency
Owner
- Apic Bio, Inc., Cambridge, MA, US
- Apic Bio, Inc., Cambridge, MA, US
Prosecution history
- 30 Jan 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 30 Jan 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 01 Jul 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jun 2022 — SOU EXTENSION 5 GRANTED
- 23 Jun 2022 — SOU EXTENSION 5 FILED
- 23 Jun 2022 — SOU TEAS EXTENSION RECEIVED
- 21 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2021 — SOU EXTENSION 4 GRANTED
- 17 Dec 2021 — SOU EXTENSION 4 FILED
- 17 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 23 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jun 2021 — SOU EXTENSION 3 GRANTED
- 21 Jun 2021 — SOU EXTENSION 3 FILED
- 21 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 22 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED